Search

You searched for "head and neck"

174 results found

Transnasal oesophagoscopy in head and neck cancer: an update

1 September 2015 |
The role of transnasal oesophagoscopy (TNE) in the management of head and neck cancer patients is evolving. Until 1990, oesphagoscopy required specialist endoscopists, general anaesthesia or sedation. This review succinctly summarises updates in the evidence for TNE in: i) Screening...

Red flag head and neck cancer symptoms

1 September 2018 |
This was a prospective study of 1589 patients that were enrolled in the Scottish Audit of Head and Neck Cancer between 1999 and 2001. It recorded their presenting symptoms and assessed their long-term survival with respect to symptoms and subsites...

Grading dysphagia as a toxicity in treating head and neck cancer

1 September 2018 | | Clinical trials, Deglutition and deglutition disorders, Head and neck cancer, Toxicity grading
Common Terminology Criteria for Adverse Events (CTCAE) is a system used by clinicians to grade the toxicity of oncology treatments in a standardised manner. Dysphagia is perhaps the most common long-term toxicity of head and neck cancer treatment. Currently, a...

Head and neck myxofibrosarcoma: a case report and review of the literature

1 March 2015 | | ENTA - Head & Neck | Malignant fibrous histiocytoma, Midcheek masses, Myxofibrosarcoma, Myxosarcoma
Myxofibrosarcoma is the most common soft tissue sarcoma that occurs in late adult life, peaking in the seventh decade, and it is mainly encountered in the lower extremities. Cases within the head and neck region are extremely rare and to...

Multiple free flaps for head and neck cancer

1 March 2015 | | ENTA - Head & Neck, ENTA - Skull Base Surgery | Complications, Free tissue transfer flaps, Head and neck cancer, Maxilla-mandibular reconstruction, Microsurgical free flaps
Most patients with advanced head and neck cancers now undergo microvascular free flap reconstruction. This is mainly as flaps facilitate complete tumour and margin removal by providing reliable wound coverage and better restoration of form and function. However despite this,...

National analysis of outcome of head and neck cancer surger

1 September 2014 |
Patient outcomes continue to become ever more visible in the NHS with ongoing drives to demonstrate transparency in our delivery of healthcare. This article reviews unit-level data publication using Hospital Episode Statistics data in all units undertaking head and neck...

Perioperative management of the head and neck cancer patient

1 March 2019 | | ENTA - Head & Neck | Antibiotic prophylaxis, Anticoagulation, Head and neck cancer, Malnutrition, Perioperative recovery, Supplementation
The perioperative care of patients with head and neck cancer is complex and requires significant preoperative planning and patient education. The issues include analgesia, antibiotics, stoma and wound care, general and chest physiotherapy, thromboprophylaxis and nutrition. This article provides a...
British Journal of Oral and Maxillofacial Surgery cover

Significance of abnormal retropharyngeal nodes in head and neck cancer

1 November 2019 | | ENTA - Rhinology / Sinus | nasopharyngeal cancer, oral, oropharyngeal, retropharyngeal nodes, squamous cell carcinoma
Abnormal retropharyngeal lymph nodes (RLN) have prognostic relevance for patients with oral, oropharyngeal or nasopharyngeal squamous cell carcinoma (SCC). However, consensus on the evaluation and management of abnormal RLN in these patients is lacking. The authors of this paper provided...

Head and neck robotic surgery – considerations for the surgical trainee

4 November 2021 | | ENTA - Head & Neck
In 2021, training in head and neck cancer surgery would be incomplete without some robotic resections under the belt. Henry Zhang explains how he did it and outlines the options available. With a wide range of applications in both benign...

Patient initiated follow-up in head and neck cancer

3 May 2024 | | ENTA - Head & Neck
Is it time for a change in the way we follow up head and neck cancer patients after treatment? Paul Nankivell and Hisham Mehanna explain the rationale for the PETNECK2 trial. After completion of curative intent treatment, clinical follow-up currently...

AI reshaping the landscape of head and neck cancer

4 July 2024 | | ENTA - Head & Neck
With artificial intelligence set to transform almost every aspect of life, Abishek Mahajan reviews its potential to improve head and neck cancer care. Artificial intelligence (AI) has emerged as a transformative tool in healthcare. In the realm of oncology, AI...

Imaging and management of head and neck vascular anomalies

1 May 2014 | | ENTA - Head & Neck, ENTA - Maxillofacial Surgery
Vascular anomalies are a diffuse spectrum of abnormalities which often involve the head, neck and oral cavity. They are frequently misnamed, often being generically labelled as haemangiomas. This lack of basic understanding can cause confusion leading to a cascade of...